Design Cloud

  • Home

  • About Us

    Company Profile HIstory Culture Honor
    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    Cardiovascular series Psychiatry series Hepatobiliary, Gastroenterology Series Respiratory series Anti-infective virus series Other series Large Infusion Series Huabao Tong Series Active Pharmaceutical Ingredient Series
    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    Academician Expert Workstation Medical Research and Industry Alliance
    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    General News Party group dynamics Employee activity
    • General News

    • Party group dynamics

    • Employee activity

  • HR

    Talent Strategy Company recruitment
    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

News

  • Home page

General News

Party group dynamics

Employee activity

Public Notice for the 2,195-Ton Annual Production Project of Active Pharmaceutical Ingredients (Phase I) by Wanbangde Pharmaceutical Group Co., Ltd.

Date:

24 Mar,2023


Public Notice Draft for Wanbangde Pharmaceutical Group Co., Ltd.'s Annual Production Project of 2,195 Tons of Active Pharmaceutical Ingredients (Phase I)

The full text is attached.

 

 

Previous page

Good News | Wanbangde Pharmaceutical Group has once again earned two prestigious awards: "Outstanding Chinese Ethnic Medicine Brand Enterprise" and "Top 50 Growing Companies in China's Pharmaceutical Industry"!

Industry-Education Integration and School-Enterprise Collaboration | Wanbangde Pharmaceutical Group Successfully Selected for the "2021–2022 Zhejiang Province Industry-Education Integrated Enterprise" List!

Next page

Related Recommendations

Image Name

2025/04/15

Good News | Warm Congratulations to Wanbande Pharmaceutical Group Co., Ltd. (Registered Trademark: wepon), which has been honored with the third batch of the "Taizhou Time-Honored Brand" title!

Image Name

2025/04/14

New peptide candidate compound: Preclinical studies in the metabolic field show promising progress.

Image Name

2025/04/14

[“Station” Success Report] | Wanbangde Pharmaceutical Group’s Postdoctoral Research Workstation Gains New Talent, Accelerating the Advancement of Innovative Drug Development!

< 1234...78 > proceed page
  • Home

  • About Us

    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    • General News

    • Party group dynamics

    • Employee activity

  • HR

    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

Website Development: China Enterprise DynamicsTaizhou

Business license
浙ICP备10002622号-38